I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Protsenko, Svetlana
97
results:
Search for persons
X
Format
Online (97)
Mediatypes
Articles (Online) (41)
OpenAccess-fulltext (56)
Languages
english (67)
russian (8)
Sorted by: Relevance
Sorted by: Year
?
1
Overall survival with first-line atezolizumab in combinatio..:
Ascierto, Paolo A
;
Stroyakovskiy, Daniil
;
Gogas, Helen
...
The Lancet Oncology. 24 (2023) 1 - p. 33-44 , 2023
Link:
https://doi.org/10.1016/..
?
2
Efficacy and safety of nurulimab+prolgolimab with continued..:
Samoylenko, Igor V.
;
Demidov, Lev V.
;
Moiseenko, Fedor V.
...
Journal of Modern Oncology. 25 (2023) 3 - p. 313-324 , 2023
Link:
https://doi.org/10.26442..
?
3
First-Line Nivolumab Plus Ipilimumab With Chemotherapy Vers..:
Paz-Ares, Luis G.
;
Ciuleanu, Tudor-Eliade
;
Cobo, Manuel
...
Journal of Thoracic Oncology. 18 (2023) 2 - p. 204-222 , 2023
Link:
https://doi.org/10.1016/..
?
4
Current concepts of neuroendocrine cancer of the prostate: ..:
Chizh, Grigoriy A.
;
Tyutrina, Yuliya A.
;
Protsenko, Svetlana A.
..
Journal of Modern Oncology. 24 (2022) 2 - p. 242-249 , 2022
Link:
https://doi.org/10.26442..
?
5
Real-world data on the incidence of immune-related adverse ..:
Degtiareva, Ekaterina
;
Protsenko, Svetlana
;
Iyevleva, Aglaya
.
Problems in oncology. 68 (2022) 2 - p. 188-199 , 2022
Link:
https://doi.org/10.37469..
?
6
Real-World Experience with Targeted Therapy in BRAF Mutant ..:
Orlova, Kristina V.
;
Ledin, Evgeniy V.
;
Zhukova, Natalia V.
...
Cancers. 13 (2021) 11 - p. 2529 , 2021
Link:
https://doi.org/10.3390/..
?
7
Influence of correction of nutritive deficiency on the effe..:
Brish, Nadezhda A.
;
Semiglazova, Tatiana Yu.
;
Karachun, Aleksei M.
...
Journal of Modern Oncology. 23 (2021) 3 - p. 519-524 , 2021
Link:
https://doi.org/10.26442..
?
8
Novel PD-1 inhibitor prolgolimab: expanding non-resectable/..:
Tjulandin, Sergey
;
Demidov, Lev
;
Moiseyenko, Vladimir
...
European Journal of Cancer. 149 (2021) - p. 222-232 , 2021
Link:
https://doi.org/10.1016/..
?
9
Individualization in the treatment of resistant forms of ge..:
Елена Ульрих
;
Teletaeva, Gulfiya
;
Semenova, Anna
...
Problems in oncology. 66 (2020) 6 - p. 667-672 , 2020
Link:
https://doi.org/10.37469..
?
10
Atezolizumab, vemurafenib, and cobimetinib as first-line tr..:
Gutzmer, Ralf
;
Stroyakovskiy, Daniil
;
Gogas, Helen
...
The Lancet. 395 (2020) 10240 - p. 1835-1844 , 2020
Link:
https://doi.org/10.1016/..
?
11
EVALUATION OF THE EFFECTIVENESS OF MODERN IMMUNOTHERAPY:
Oganesian, A.
;
Protsenko, Svetlana
;
Baldueva, Irina
...
Problems in oncology. 66 (2020) 3 - p. 211-217 , 2020
Link:
https://doi.org/10.37469..
?
12
Nivolumab in patients with metastatic renal cell carcinoma ..:
Tsimafeyeu, Ilya
;
Gafanov, Rustem
;
Protsenko, Svetlana
...
Cancer Immunology, Immunotherapy. 69 (2020) 6 - p. 983-988 , 2020
Link:
https://doi.org/10.1007/..
?
13
NEOADJUVANT FOR PATIENTS WITH HIGH AND VERY HIGH RISK PROST..:
Nosov, A.
;
Reva, Sergey
;
Berkut, M.
...
Problems in oncology. 65 (2019) 5 - p. 726-735 , 2019
Link:
https://doi.org/10.37469..
?
14
EFFICACY OF NIVOLUMAB (NWO) DURING 2+ LINE TREATMENT AND QU..:
Laktionov, Konstantin
;
Arzumanyan, Alla
;
Bolotina, Larisa
...
Problems in oncology. 65 (2019) 1 - p. 99-105 , 2019
Link:
https://doi.org/10.37469..
?
15
IPILIMUMAB IN PATIENTS WITH DISSEMINATED MELANOMA: THE N.N...:
Anokhina, Yekaterina
;
Rubinchik, V.
;
Yaremenko, Yekaterina
...
Problems in oncology. 64 (2018) 3 - p. 388-393 , 2018
Link:
https://doi.org/10.37469..
1-15